Autoimmunity triggers in the NOD mouse: A role for natural auto-antibody reactivities in type 1 diabetes

Annals of the New York Academy of Sciences

Volumn 1173, Issue , 2009, Pages 442-448

  Côrte Real, Joana ^a   Duarte, Nádia ^a   Tavares, Luís ^b   Penha Gonçalves, Carlos ^a  

^a INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

^b FACULDADE DE MEDICINA VETERINÁRIA   (Portugal)

Author keywords

Natural auto antibodies; NOD; Type 1 diabetes

Indexed keywords

AUTOANTIGEN;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY PRODUCTION; AUTOIMMUNITY; B LYMPHOCYTE; CELL STRAIN; CONFERENCE PAPER; DIABETOGENESIS; DISEASE COURSE; GENETIC ANALYSIS; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET;

EID: 69949139910     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04661.x     Document Type: Conference Paper

References (31)

1. Yang, Y. & P. Santamaria. 2003. Dissecting autoimmune diabetes through genetic manipulation of non-obese diabetic mice. Diabetologia 46: 1447-1464.
2. Bach, J.F. 1994. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr. Rev. 15: 516-542.
3. Castano, L. & G.S. Eisenbarth. 1990. Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu. Rev. Immunol. 8: 647-679.
4. Ghosh, S. et al. 1993. Polygenic control of autoimmune diabetes in nonobese diabetic mice. Nat. Genet. 4: 404-409.
5. Akashi, T. et al. 1997. Direct evidence for the contribution of B cells to the progression of insulitis and the development of diabetes in non-obese diabetic mice. Int. Immunol. 9: 1159-1164.
6. Hulbert, C. et al. 2001. B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice. J. Immunol. 167: 5535-5538.
7. Wong, F.S. et al. 2004. Investigation of the role of B-cells in type 1 diabetes in the NOD mouse. Diabetes 53: 2581-2587.
8. Martin, F. & A.C. Chan. 2004. Pathogenic roles of B cells in human autoimmunity; insights from the clinic. Immunity 20: 517-527.
9. Inoue, Y. et al. 2007. Activating Fc gamma receptors participate in the development of autoimmune diabetes in NOD mice. J. Immunol. 179: 764-774.
10. Bonifacio, E. et al. 2001. International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice. Diabetes 50: 2451-2458. (Pubitemid 33642761)
11. Bingley, P.J. et al. 1997. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes 46: 1701-1710.
12. Greeley, S.A. et al. 2002. Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat. Med. 8: 399-402.
13. Thomas, J.W., P.L. Kendall & H.G. Mitchell. 2002. The natural autoantibody repertoire of nonobese diabetic mice is highly active. J. Immunol. 169: 6617-6624.
14. Herzenberg, L.A. 2000. B-1 cells: the lineage question revisited. Immunol. Rev. 175: 9-22.
15. Dorshkind, K. & E. Montecino-Rodriguez. 2007. Fetal B-cell lymphopoiesis and the emergence of B-1-cell potential. Nat. Rev. Immunol. 7: 213-219.
16. Coutinho, A., M.D. Kazatchkine & S. Avrameas. 1995. Natural autoantibodies. Curr. Opin. Immunol. 7: 812-818.
17. Rojas, M., C. Hulbert & J.W. Thomas. 2001. An-ergy and not clonal ignorance determines the fate of B cells that recognize a physiological autoantigen. J. Immunol. 166: 3194-3200.
18. Ichiyoshi, Y., M. Zhou & P. Casali. 1995. A human anti-insulin IgG autoantibody apparently arises through clonal selection from an insulin-specific "germ-line" natural antibody template. Analysis by V gene segment reassortment and site-directed mu-tagenesis. J. Immunol. 154: 226-238.
19. Kendall, P.L. et al. 2004. Peritoneal B cells govern the outcome of diabetes in non-obese diabetic mice. Eur. J. Immunol. 34: 2387-2395.
20. Shibuya, A. et al. 2000. Fc alpha/mu receptor mediates endocytosis of IgM-coated microbes. Nat. Immunol. 1: 441-446.
21. Ehrenstein, M.R. et al. 1998. Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc. Natl. Acad. Sci. USA 95: 10089-10093.
22. Takai, T. 2002. Roles of Fc receptors in autoimmu-nity. Nat. Rev. Immunol. 2: 580-592.
23. Reijonen, H. et al. 2000. GAD65-specific autoanti-bodies enhance the presentation of an immunodom-inant T-cell epitope from GAD65. Diabetes 49: 1621-1626.
24. Jaume, J.C. et al. 2002. Suppressive effect of glutamic acid decarboxylase 65-specific autoimmune B lymphocytes on processing of T cell determinants located within the antibody epitope. J. Immunol. 169: 665-672.
25. Shieh, D.C. et al. 1993. Insulin-dependent diabetes in the NOD mouse model. I. Detection and characterization of autoantibody bound to the surface of pancreatic beta cells prior to development of the in-sulitis lesion in prediabetic NOD mice. Autoimmunity 15: 123-135.
26. Pleau, J.M. et al. 1996. Glutamic acid decarboxylase (GAD 67) gene expression in the pancreas and brain of the nonobese diabetic mouse. Biochem. Biophys. Res. Commun. 224: 747-753.
27. Kim, K.S. et al. 2002. Modulation of glucocorticoid-induced GAD expression in pancreatic beta-cells by transcriptional activation of the GAD67 promoter and its possible effect on the development of diabetes. Diabetes 51: 2764-2772.
28. Knip M. & H. Siljander. 2008. Autoimmune mechanisms in type 1 diabetes. Autoimmun. Rev. 7: 550-557.
29. Bresson, D. & M. von Herrath. 2007. Moving towards efficient therapies in type 1 diabetes: to combine or not to combine? Autoimmun. Rev. 6: 315-322.
30. Marino, E. & S.T. Grey. 2008. A new role for an old player: Do B cells unleash the self-reactive CD8+ T cell storm necessary for the development of type 1 diabetes? J. Autoimmun. 31: 301-305.
31. Poletaev, A.B., V.L. Stepanyuk & M.E. Gershwin. 2008. Integrating immunity: the immunculus and self-reactivity. J. Autoimmun. 30: 68-73.